NASDAQ: SNDXSyndax Pharmaceuticals Inc Stock Ownership - Who owns Syndax Pharmaceuticals?
Insider buying vs selling
Have Syndax Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Nicholas Aj Botwood | Head of RD CMO | 2026-06-12 | 31,235 | $13.82 | $431.67kBuy |
| Nicholas Aj Botwood | Head of RD CMO | 2026-06-12 | 31,235 | $18.14 | $566.60kSell |
| Nicholas Aj Botwood | Head of RD CMO | 2026-06-11 | 34,280 | $18.00 | $617.04kSell |
| Nicholas Aj Botwood | Head of RD CMO | 2026-06-11 | 22,515 | $13.82 | $311.16kBuy |
| Keith A. Goldan | Chief Financial Officer | 2026-06-01 | 1,177 | $18.99 | $22.35kSell |
| Michael A. Metzger | Chief Executive Officer | 2026-06-01 | 6,847 | $18.99 | $130.02kSell |
| Michael A. Metzger | Chief Executive Officer | 2026-02-09 | 17,159 | $21.03 | $360.82kSell |
| Keith A. Goldan | Chief Financial Officer | 2026-02-09 | 3,410 | $21.03 | $71.71kSell |
| Michael A. Metzger | Chief Executive Officer | 2026-02-06 | 7,412 | $20.62 | $152.84kSell |
| Keith A. Goldan | Chief Financial Officer | 2026-02-06 | 2,082 | $20.62 | $42.93kSell |
SNDX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SNDX insiders and whales buy or sell their stock.
SNDX Shareholders
What type of owners hold Syndax Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 9.32% | 8,254,426 | $175.90M | Institution |
| Kynam Capital Management LP | 9.09% | 8,050,959 | $171.57M | Institution |
| Goldman Sachs Group Inc 1 | 5.64% | 4,996,787 | $106.48M | Institution |
| State Street Corp | 5.00% | 4,430,076 | $94.40M | Institution |
| Bank Of America Corp | 4.80% | 4,249,836 | $90.56M | Institution |
| Vanguard Capital Management LLC | 4.31% | 3,822,579 | $81.46M | Institution |
| Deerfield Management Company LP | 4.27% | 3,779,900 | $80.55M | Institution |
| Eversept Partners LP | 3.26% | 2,885,622 | $61.49M | Institution |
| Kingdon Capital Management LLC | 2.82% | 2,500,000 | $53.28M | Institution |
| Hood River Capital Management LLC | 2.66% | 2,354,285 | $50.17M | Institution |
SNDX vs Biotech Stocks
Syndax Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.